Recombinant Anti-FABP12 antibody [EPR10536] (ab155089)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR10536] to FABP12
- Suitable for: WB, Flow Cyt, ICC/IF
- Reacts with: Mouse, Rat, Human
Overview
-
Product name
Anti-FABP12 antibody [EPR10536]
See all FABP12 primary antibodies -
Description
Rabbit monoclonal [EPR10536] to FABP12 -
Host species
Rabbit -
Tested Applications & Species
Application Species Flow Cyt HumanICC/IF HumanWB Rat -
Immunogen
Synthetic peptide, corresponding to residues in Human FABP12 (UniProt: A6NFH5).
-
Positive control
- Rat eyeball, Mouse eyeball, Human fetal brain and Jurkat lysates; Jurkat cells.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at -20ºC. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading...
-
Purity
Tissue culture supernatant -
Clonality
Monoclonal -
Clone number
EPR10536 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
-
Positive Controls
-
Recombinant Protein
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab155089 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Tested applications are guaranteed to work and covered by our Abpromise guarantee.
Predicted to work for this combination of applications and species but not guaranteed.
Does not work for this combination of applications and species.
Application | Species |
---|---|
Flow Cyt |
Human
|
ICC/IF |
Human
|
WB |
Rat
|
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000 - 1/10000. Predicted molecular weight: 16 kDa.
|
|
Flow Cyt |
1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
|
|
ICC/IF |
1/50 - 1/100.
|
Notes |
---|
WB
1/1000 - 1/10000. Predicted molecular weight: 16 kDa. |
Flow Cyt
1/10 - 1/100. ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
|
ICC/IF
1/50 - 1/100. |
Target
-
Function
May play a role in lipid transport. -
Tissue specificity
Expressed in a number of retinoblastoma cell lines. -
Sequence similarities
Belongs to the calycin superfamily. Fatty-acid binding protein (FABP) family. -
Developmental stage
Not detected in fetal tissues. - Information by UniProt
-
Database links
- Entrez Gene: 646486 Human
- Entrez Gene: 75497 Mouse
- Entrez Gene: 499570 Rat
- SwissProt: A6NFH5 Human
- SwissProt: Q9DAK4 Mouse
- SwissProt: B7SUM8 Rat
- Unigene: 586370 Human
- Unigene: 47052 Mouse
see all -
Alternative names
- FABP12 antibody
- Fatty acid binding protein ORF antibody
- Fatty acid-binding protein 12 antibody
see all
Images
-
All lanes : Anti-FABP12 antibody [EPR10536] (ab155089) at 1/1000 dilution
Lane 1 : Rat eyeball lysate
Lane 2 : Mouse eyeball lysate
Lane 3 : Human fetal brain lysate
Lane 4 : Jurkat cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 16 kDa -
Immunofluorescent analysis of Jurkat cells labeling FABP12 with ab155089 at 1/50 dilution.
-
Flow cytometric analysis of permeabilized Jurkat cells, labeling FABP12 with ab155089 at 1/10 dilution (red) compared with a Rabbit IgG control (green).
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab155089 has not yet been referenced specifically in any publications.